Smithfield Trust’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15K Hold
80
﹤0.01% 834
2026
Q1
$7K Hold
80
﹤0.01% 934
2025
Q4
$6K Hold
80
﹤0.01% 954
2025
Q3
$8K Hold
80
﹤0.01% 894
2025
Q2
$6K Hold
80
﹤0.01% 936
2025
Q1
$4K Hold
80
﹤0.01% 980
2024
Q4
$6K Hold
80
﹤0.01% 948
2024
Q3
$8K Hold
80
﹤0.01% 868
2024
Q2
$11K Hold
80
﹤0.01% 793
2024
Q1
$9K Hold
80
﹤0.01% 844
2023
Q4
$10K Buy
+80
New +$11K ﹤0.01% 822

Other funds holding ACLS

Smithfield Trust's ACLS Position: Q2 2026 in Review

Smithfield Trust held its Axcelis (ACLS) position steady in Q2 2026 at 80 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #834.

Smithfield Trust first reported a position in ACLS in Q4 2023 and has held it in 11 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Smithfield Trust held 80 shares of Axcelis worth $15K as of Q2 2026.
  • Smithfield Trust left its Axcelis share count unchanged in Q2 2026.
  • Axcelis made up ﹤0.01% of Smithfield Trust's portfolio in Q2 2026, its #834 holding.
  • Smithfield Trust first reported a position in Axcelis in Q4 2023 and has held it in 11 quarters since.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Smithfield Trust's 13F filing for Q2 2026, filed 5 Aug 2026.